Table 1.

Real-world overall survival among men with LPC/LAPC identified from claims and EHR data who survived 1, 3, 4, and 5 years after start of primary treatment, according to evidence of disease during each time period

Time from initiation of primary treatment (years)	Survival probability (%)
	Evidence of disease within 1 year		Evidence of disease within 3 years		Evidence of disease within 4 years		Evidence of disease within 5 years
	Yes	No	Yes	No	Yes	No	Yes	No
Claims survival data	n = 1959	n = 43,480	n = 2156	n = 21,557	n = 1772	n = 14,991	n = 1332	n = 10,339
At 6 years	68.6	83.5	75.5	90.1	82.4	93.3	90.4	96.8
At 7 years	65.1	79.2	70.3	86.0	75.5	89.5	81.7	93.1
At 8 years	62.8	74.1	65.2	81.0	69.7	84.6	74.5	88.4
EHR survival data	n = 2502	n = 46,487	n = 3736	n = 26,802	n = 3280	n = 19,642	n = 2719	n = 13,776
At 6 years	69.5	86.2	78.0	91.9	83.9	94.9	92.1	97.5
At 7 years	62.9	81.9	70.0	87.9	75.7	91.1	82.9	94.0
At 8 years	55.2	77.4	62.3	83.4	67.2	86.7	74.7	89.7

EHR electronic health records, LAPC locally advanced prostate cancer, LPC localized prostate cancer